S
Susana Ferreira
Researcher at University of Porto
Publications - 52
Citations - 1407
Susana Ferreira is an academic researcher from University of Porto. The author has contributed to research in topics: Allele & Population. The author has an hindex of 16, co-authored 52 publications receiving 1276 citations. Previous affiliations of Susana Ferreira include Centro Hospitalar de Vila Nova de Gaia/Espinho & Instituto Português de Oncologia Francisco Gentil.
Papers
More filters
Journal ArticleDOI
N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients
Paulo Bettencourt,Ana Azevedo,Joana Pimenta,Fernando Friões,Susana Ferreira,António Ferreira +5 more
TL;DR: Variations in NT-proBNP levels are related to hospital readmission and death within 6 months and are potentially useful in the evaluation of treatment efficacy and might help clinicians in planning discharge of HF patients.
Journal ArticleDOI
Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study--screening genetic conditions in Portuguese young stroke patients.
Miguel Viana Baptista,Susana Ferreira,Teresa Pinho-e-Melo,Marta Carvalho,Vítor Tedim Cruz,Cátia Carmona,Fernando Silva,Assunção Tuna,Miguel Rodrigues,Carla Ferreira,Ana Amélia Nogueira Pinto,André Leitão,João Paulo Gabriel,Sofia Calado,João Paulo Oliveira,José M. Ferro +15 more
TL;DR: Despite a low diagnostic yield, screening for GLA mutations should probably be considered in different types of stroke, because Restricting investigation to patients with cryptogenic stroke may underestimate the true prevalence of Fabry disease in young patients with stroke.
Journal ArticleDOI
Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure.
TL;DR: These preliminary results in a small number of patients suggest that changes in B-type natriuretic peptide levels, as well as predischarge levels, are related to hospital readmission and death within 6 months.
Journal ArticleDOI
The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.
Susana Ferreira,Alberto Ortiz,Dominique P. Germain,Miguel Viana-Baptista,António Caldeira-Gomes,Marta Camprecios,Maria Fenollar-Cortés,Angel Gallegos-Villalobos,Diego Garcia,José Antonio García-Robles,Jesús Egido,Eduardo Gutiérrez-Rivas,José Antonio Herrero,Sebastian Mas,Raluca Oancea,Paloma Péres,Luis Manuel Salazar-Martín,Jesús Solera-Garcia,Helena Alves,Scott C. Garman,João Paulo Oliveira +20 more
TL;DR: Clinical, biochemical and histopathology data strongly suggest that the GLA p.(Arg118Cys) variant does not segregate with FD clinical phenotypes in a Mendelian fashion, but might be a modulator of the multifactorial risk of cerebrovascular disease.
Journal ArticleDOI
Prevalence and characteristics of sleep apnoea in patients with stable heart failure: Results from a heart failure clinic
Susana Ferreira,Anabela Marinho,Marta Patacho,Elisabete Santa-Clara,Cristina Carrondo,João Carlos Winck,Paulo Bettencourt +6 more
TL;DR: The results suggest that SA is under diagnosed in HF and there is a possible correlation between them, independent of confounding factors, and recent advances in HF therapy might influence prevalence and type of SA in this population.